An innovative service company focusing on the field of drug quality control


Contact Us

You are here:Home >> News >> Company News

Company News

SZEB Supplies Afatinib Impurities

Time:2022-07-15 Views:61
       Afatinib,is a medication used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications.
       Afatinib is an oral, irreversible ErbB family blocker that covalently binds to the kinase domains of epidermal growth factor receptor (EGFR), human EGFRs (HER) 2, and HER4, resulting in irreversible inhibition of tyrosine kinase autophosphorylation. 
       To support your analysis and help ensure the accuracy of quality processes, we supply a range of Afatinib-related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.
       The following are some of the impurities of Afatinib: